Form 4 for KVUE Kenvue
Accepted 2023-08-25 00:00:00 ET · period of report 2023-08-23 · accession 0001944048-23-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-25 | 2023-08-23 | KVUE | Sneed Michael E | Dir | J - Other | — | +10.8K | 10.8K | New | — |
| D | 2023-08-25 | 2023-08-23 | KVUE | Sneed Michael E | Dir | A - Grant | $0.00 | +7,620 | 7,620 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-23 | J | A | 10,787 | — | 10,787 | D | — | — | (F1) On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. |
| 2 | Derivative | Deferred Share Units | 2023-08-23 | A | A | 7,620 | $0.00 | 7,620 | D | — · — to — | 7,620 Common Stock | (F2) Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). |